Systemic Sclerosis & Related Disorders – Clinical Poster III
Sunday, November 8, 2020
9:00 AM – 11:00 AM ET
Poster session.
Presentations:
9:00 AM – 11:00 AM ET
Raynaud's Phenomenon and Systemic Sclerosis in Post-9/11 Deployed Veterans Receiving Care Veterans Health Administration Care Tracy Frech, MD – University of Utah
9:00 AM – 11:00 AM ET
Understanding Diagnostic Pathways in Systemic Sclerosis and Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) Shervin Assassi, MD, MS – University of Texas McGovern Medical School at Houston
9:00 AM – 11:00 AM ET
Clinical Outcomes Among Participants with Diffuse Systemic Sclerosis Contracting COVID-19 During Clinical Studies of Lenabasum: A Case Series Robyn T. Domsic, MD, MPH – University of Pittsburgh
9:00 AM – 11:00 AM ET
Digital Occlusive Arterial Disease on Laser Doppler Flowmetry Increases the Risk of Digital Ischemic Complications in Systemic Sclerosis: Results from a Single Center Referral Cohort (2001-2018) Yasser A. Radwan, MD – Mayo Clinic/ Michigan State University
9:00 AM – 11:00 AM ET
Real-World Mono-, Double and Triple Combination Treatment Patterns with Macitentan in Patients with Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (PAH-CTD): Evidence from the Combined OPUS/OrPHeUS Dataset Matthew Lammi, MD – Lousiana State University Health Sciences Center
9:00 AM – 11:00 AM ET
Changes in Imaging Markers in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) Treated with Nintedanib: Sub-Study of the SENSCIS Trial Stephen Humphries, PhD – National Jewish Health
9:00 AM – 11:00 AM ET
Tocilizumab Shows Potential in Preserving Lung Function in Systemic Sclerosis with Positive anti-topoisomerase-1 (Scl-70): A Single Centre Cohort Study Yasir Suleman, MBBS, BSc – Royal Free Hospital London NHS Trust
9:00 AM – 11:00 AM ET
Usage, Needs and Preferences Regarding Physical Therapy in Patients with Systemic Sclerosis Sophie Liem, MD – LUMC
9:00 AM – 11:00 AM ET
Physical Therapy in Patients with Systemic Sclerosis: The Perspective of Physical Therapists on Current Delivery and Educational Needs Sophie Liem, MD – LUMC
9:00 AM – 11:00 AM ET
Clinical Correlates and Relevance of the UCLA GIT 2.0 Instrument for Indication for Esophagogastroduodenoscopy and Endoscopic Esophagitis in Real-life Patients with Systemic Sclerosis Carina Mihai, MD – Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland
9:00 AM – 11:00 AM ET
Should Systemic Sclerosis Patients with Low Bicarbonate Have Replacement to Prevent Renal Dysfunction? Megan Meier, MD – University of Utah
9:00 AM – 11:00 AM ET
A Systematic Assessment of Demographics, Clinical and Serological Features Associated with Colonic Hypomotility in Systemic Sclerosis Jenice Cheah, BS – Johns Hopkins University School of Medicine
9:00 AM – 11:00 AM ET
Clinical Characteristics and Treatment Outcome of a Cohort of Patients with Joint and Fascial Involvement in the Context of Chronic Graft versus Host Disease Cristina Hidalgo, Sr, MD – Hospital Universitario Salamanca
9:00 AM – 11:00 AM ET
Outcomes of Systemic Sclerosis Patients Who Were Primarily Admitted for Acute Myocardial Infarction from 2016 to 2017: Insights from the National Inpatient Sample Atefeh Vafa, MD – USF
9:00 AM – 11:00 AM ET
Associations Between Autoantibodies in Systemic Sclerosis and Cancer in a National Registry Selma Lazizi, MD – Université de Montréal
9:00 AM – 11:00 AM ET
Long-Term Tolerability of Aminaphtone in Raynaud's Phenomenon Secondary to Systemic Sclerosis Alberto Sulli, MD – Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS San Martino Polyclinic Hospital, Genoa, Italy.
9:00 AM – 11:00 AM ET
Systemic Sclerosis: Subclinical Aterosclerosis and Morbimortality Miriam Retuerto, MD – Hospital universitario 12 de octubre
9:00 AM – 11:00 AM ET
Pathway to Systemic Sclerosis: Concerning Patients’ Experiences During the Diagnostic Process Patricia Fennell, MSW – Albany Health Management Associates, Inc. Steffens Scleroderma Foundation
9:00 AM – 11:00 AM ET
Poor Maternal and Fetal Outcome in Indian Women with Systemic Sclerosis: Interview-based Study at a Tertiary Center in India Vikas Agarwal – SGPGIMS
Clinical and Demographic Features of Morphea Patients with Mucocutaneous Involvement: A Cross Sectional Study from the Morphea of Adults and Children Cohort Samantha Black, BS – The University of Texas Southwestern Medical Center
9:00 AM – 11:00 AM ET
The Isolated Nucleolar Pattern ANA Antibody in a Systemic Sclerosis Patient Cohort Sabrina Elliott, MS – Georgetown University Medical Center
